As IP3R is also known to regulate autophagy and metabolism [1], we also compared serum metabolic profiles among healthy subjects and breast cancer patients with high IP3R and low IP3R. We determined that the NMR-derived fingerprint of the serum metabolic profile is able to help discriminate among breast cancer patients with high and low IP3R expression and healthy controls. This evidence concerns the gene ITPR3 and breast cancer.